Form 4: Disc Medicine's Chief Medical Officer Sells Shares Under 10b5-1 Trading Plan

William Jacob Savage, Chief Medical Officer of Disc Medicine, Inc., sold 2,100 shares of common stock on May 2, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 2, 2025, William Jacob Savage, the Chief Medical Officer of Disc Medicine, Inc. (IRON), sold 2,100 shares of the company's common stock.
• The sale was executed at a weighted average price of $50.1748 per share, with individual transactions ranging from $50.06 to $50.21.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on November 18, 2024.
• Following the reported transaction, Savage directly owns 66,398 shares of Disc Medicine, Inc.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a stock sale under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of insider trading. The sale itself doesn't necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

Form 4, Disc Medicine, IRON, William Jacob Savage, Chief Medical Officer, Stock Sale, Rule 10b5-1 Trading Plan, Insider Trading